Press the button and be introduced to a new random company!

Introduce me >

Social media

facebook   Follow us on Twitter

Coverage

IRLAB Therapeutics

IRLAB Therapeutics

Send subscription Close

Financials

SEKm 2023 2024e 2025e
Sales 6 189 411
Sales growth (%) -90,7 3195,6 118,3
EBITDA -176 -7 160
EBITDA margin (%) -3084,8 -3,5 39
EBIT adj. -181 -11 156
EBIT adj. margin (%) -3160,2 -6 38
Pretax profit -178 -19 156
EPS -3,43 -0,37 3,01
EPS growth (%) 56,8 -89,2 -914,4
EPS adj. -3,43 -0,37 3,01
DPS 0 0 0
EV/EBITDA (x) -3,1 -84,6 2,5
EV/EBIT adj. (x) -3 -50 2,6
P/E (x) -3,5 -32,8 4
P/E adj. (x) -3,5 -32,8 4
EV/sales (x) 95,08 2,99 0,99
FCF yield (%) -26,3 -2,7 25,3
Le. adj. FCF yld. (%) -26,3 -2,7 25,5
Dividend yield (%) 0 0 0
Net IB debt/EBITDA (x) 0,5 10 -1,4
Le. adj. ND/EBITDA (x) 0 0 0
SEKm 2023 2024e 2025e
Sales 6 189 411
COGS N/A N/A N/A
Gross profit 6 189 411
Other operating items -182 -195 -251
EBITDA -176 -7 160
Depreciation and amortisation -4 -5 -4
of which leasing depreciation 0 0 0
EBITA -181 -11 156
EO Items N/A N/A N/A
Impairment and PPA amortisation 0 0 0
EBIT -181 -11 156
Net financial items 3 -8 0
Pretax profit -178 -19 156
Tax 0 0 0
Net profit -178 -19 156
Minority interest N/A N/A N/A
Net profit discontinued N/A N/A N/A
Net profit to shareholders -178 -19 156
EPS -3,43 -0,37 3,01
EPS adj. -3,43 -0,37 3,01
Total extraordinary items after tax 0 0 0
Leasing payments 0 0 0
Tax rate (%) 0 0 0
Gross margin (%) 100 100 100
EBITDA margin (%) -3084,8 -3,5 39
EBITA margin (%) -3160,2 -6 38
EBIT margin (%) -3160,2 -6 38
Pre-tax margin (%) -3109,1 -10,2 37,9
Net margin (%) -3109,1 -10,2 37,9
Growth Rates y-o-y N/A N/A N/A
Sales growth (%) -90,7 3195,6 118,3
EBITDA growth (%) 62,9 -96,2 -2507,3
EBITA growth (%) 59,8 -93,8 -1487,5
EBIT growth (%) 59,8 -93,8 -1487,5
Net profit growth (%) 56,8 -89,2 -914,4
EPS growth (%) 56,8 -89,2 -914,4
Profitability N/A N/A N/A
ROE (%) -87,5 -18 89,3
ROE adj. (%) -87,5 -18 89,3
ROCE (%) -82,3 -6,3 77,8
ROCE adj. (%) -82,3 -6,3 77,8
ROIC (%) -535,5 -38 499,1
ROIC adj. (%) -535,5 -38 499,1
Adj. earnings numbers N/A N/A N/A
EBITDA adj. -176 -7 160
EBITDA adj. margin (%) -3084,8 -3,5 39
EBITDA lease adj. -176 -7 160
EBITDA lease adj. margin (%) -3084,8 -3,5 39
EBITA adj. -181 -11 156
EBITA adj. margin (%) -3160,2 -6 38
EBIT adj. -181 -11 156
EBIT adj. margin (%) -3160,2 -6 38
Pretax profit Adj. -178 -19 156
Net profit Adj. -178 -19 156
Net profit to shareholders adj. -178 -19 156
Net adj. margin (%) -3109,1 -10,2 37,9
SEKm 2023 2024e 2025e
EBITDA -176 -7 160
Goodwill N/A N/A N/A
Net financial items 3 -8 0
Other intangible assets 47 47 47
Paid tax 0 0 0
Tangible fixed assets 7 7 7
Non-cash items 0 -2 -1
Right-of-use asset N/A N/A N/A
Cash flow before change in WC -173 -16 159
Total other fixed assets 0 0 0
Change in working capital 9 0 0
Fixed assets 54 54 54
Operating cash flow -165 -17 159
Inventories N/A N/A N/A
Capex tangible fixed assets 0 0 0
Receivables 12 11 11
Capex intangible fixed assets N/A N/A N/A
Other current assets N/A N/A N/A
Acquisitions and Disposals 0 0 0
Cash and liquid assets 111 117 222
Free cash flow -165 -17 159
Total assets 177 182 287
Dividend paid N/A N/A N/A
Shareholders equity 116 97 253
Share issues and buybacks 0 0 0
Minority N/A N/A N/A
Leasing liability amortisation 0 0 1
Total equity 116 97 253
Other non-cash items -1 -4 -6
Long-term debt 25 51 0
Pension debt N/A N/A N/A
Convertible debt N/A N/A N/A
Leasing liability 0 0 2
Total other long-term liabilities 0 0 0
Short-term debt N/A N/A N/A
Accounts payable 3 2 N/A
Other current liabilities 34 32 32
Total liabilities and equity 177 182 287
Net IB debt -87 -66 -220
Net IB debt excl. pension debt -87 -66 -220
Net IB debt excl. leasing -87 -66 -222
Capital employed 140 147 255
Capital invested 29 30 32
Working capital -24 -23 -21
Market cap. diluted (m) 628 628 628
Net IB debt adj. -84 -64 -220
Market value of minority 0 0 0
Reversal of shares and participations 0 0 0
Reversal of conv. debt assumed equity N/A N/A N/A
EV 544 563 407
Total assets turnover (%) 2,3 105,1 175,6
Working capital/sales (%) -357,4 -12,6 -5,4
Financial risk and debt service N/A N/A N/A
Net debt/equity (%) -74,9 -68,6 -87,2
Net debt / market cap (%) -13,8 -10,6 -35,1
Equity ratio (%) 65,4 53,2 88
Net IB debt adj. / equity (%) -72,3 -66,5 -87,2
Current ratio 3,36 3,72 7,23
EBITDA/net interest 60,3 0,8 400,9
Net IB debt/EBITDA (x) 0,5 10 -1,4
Net IB debt/EBITDA lease adj. (x) 0 0 0
Interest coverage 892,7 0,9 390,9
SEKm 2023 2024e 2025e
Shares outstanding adj. 52 52 52
Diluted shares adj. 52 52 52
EPS -3,43 -0,37 3,01
Dividend per share 0 0 0
EPS adj. -3,43 -0,37 3,01
BVPS 2,23 1,86 4,87
BVPS adj. 1,33 0,96 3,97
Net IB debt/share -1,61 -1,24 -4,25
Share price 12,1 12,1 12,1
Market cap. (m) 628 628 628
P/E (x) -3,5 -32,8 4
EV/sales (x) 95,08 2,99 0,99
EV/EBITDA (x) -3,1 -84,6 2,5
EV/EBITA (x) -3 -50 2,6
EV/EBIT (x) -3 -50 2,6
Dividend yield (%) 0 0 0
FCF yield (%) -26,3 -2,7 25,3
Le. adj. FCF yld. (%) -26,3 -2,7 25,5
P/BVPS (x) 5,42 6,5 2,48
P/BVPS adj. (x) 9,11 12,62 3,05
P/E adj. (x) -3,5 -32,8 4
EV/EBITDA adj. (x) -3,1 -84,6 2,5
EV/EBITA adj. (x) -3 -50 2,6
EV/EBIT adj. (x) -3 -50 2,6
EV/CE (x) 3,9 3,8 1,6
Investment ratios N/A N/A N/A
Capex/sales (%) 5,1 0 0
Capex/depreciation 0,1 0 0
Capex tangibles / tangible fixed assets 4,4 0 0
Capex intangibles / definite intangibles 0 0 0
Depreciation on intang / def. intang 0 0 0
Depreciation on tangibles / tangibles 64,69 69,06 59,95

Key Figure Counter

It is not always easy to generate comparative valuations. Therefore, in order to make it easier for you as an investor, we have created this key figure calculator. Enter share price in the field below and then select the year in which you want to retrieve the financial data.

Update

P/E

Learn more

A common valuation multiple, the share price is divided by earnings per share.

P/E ratio stands for Price and Earnings. By dividing a company's market cap to its earnings, investors get a key ratio which they are able to compare between different companies. The ratio can either be calculated on historical or forward-looking numbers. 

It is important to notice that earnings are calculated after taxes, which mean that they can vary between companies due to different accounting standards.

4,0

EV/EBIT

Learn more

EV stands for Enterprise Value and is calculated as a company's markets cap in addition to its net debt. The net debt itself is computed through the company's interest-bearing debt minus total cash and cash equivalents. 

EBIT is the Earnings Before Interest and Taxes which is the operating income. This result, in comparison to the P/E ratio, is not affected by any financial items.

(
)
2,6

EV/Sales

Learn more

EV stands for Enterprise Value and is calculated as a company's market cap adjusted for its net debt. The net debt itself is computed through the company's interest-bearing debt minus total cash and cash equivalents. S is the company's total sales.

(
)
1,0

P/BVPS

Learn more

P/B stands for Price to Book, which is used to compare a share's market cap to its book value. A P/B ratio that is below one is considered to be valued below its assets.

Companies with high return on equity are usually associated with high P/B ratios, and vice versa. 

 

(
)
2,5